|
|
|
| Relationship between homocysteine and sarcopenia in the elderly population |
| DU Yutian1, ZHANG Li1, LIAO Xinyi2, ZHANG Suqiong3, TANG Jing1, CHENG Daomei1
|
1. School of Public Health, Chengdu Medical College, Chengdu, Sichuan 610500, China;
2. West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China;
3. Shibantan Township Health Center, Xindu District, Chengdu, Sichuan 610511, China |
|
|
|
|
Abstract Objective To investigate the relationship between total homocysteine (tHcy) levels and sarcopenia among the elderly, so as to provide insights into the prevention and treatment of sarcopenia. Methods The elderly aged 65 years and older who participated in the physical examination of Shibantan Township Health Center in Xindu District, Chengdu City from April to June 2021 was selected as the study subjects. The elderly with sarcopenia (diagnosed according to the diagnostic criteria of the Asian Sarcopenia Working Group in 2019) and non-sarcopenia were matched 1︰1 by gender and age (±2 years). Demographic information, skeletal muscle mass, skeletal muscle strength and tHcy were collected through questionnaire surveys, physical examination and laboratory testing. Multivariable conditional logistic regression model was used to explore the relationship between tHcy and sarcopenia. Results A total of 320 individuals, including 160 sarcopenia patients and 160 non-sarcopenia individuals, were investigated. There were 138 males (43.13%) and 182 females (56.87%), with a median age of 71.00 (interquartile range, 6.00) years. There were 57 drinkers (17.81%), 78 smokers (24.37%), 173 cases of hypertension (54.06%) and 124 cases of hyperhomocysteinemia (38.80%). Multivariable conditional logistic regression analysis showed that elevated tHcy was associated with an increased risk of sarcopenia (OR=1.107, 95%CI: 1.024-1.197), after adjusting for smoking, alcohol consumption, hypertension, waist circumference, neck circumference, body mass index, platelet count and high density lipoprotein cholesterol. Conclusion Elevated tHcy is associated with sarcopenia, and intervention should be carried out for the elderly with higher tHcy.
|
|
Received: 13 September 2023
Revised: 22 January 2024
Published: 20 March 2024
|
|
|
|
|
|
[1] CRUZ-JENTOFT A J,BAEYENS J P,BAUER J M,et al. Sarcopenia:European consensus on definition and diagnosis:report of the European Working Group on Sarcopenia in Older People[J]. Age ageing,2010,39(4):412-423.
[2] 崔华,王朝晖,吴剑卿,等. 老年人肌少症防控干预中国专家共识(2023)[J] . 中华老年医学杂志,2023,42(2):144-153.
[3] 杨延平,刘晓红,朱建良,等. 丽水市职业人群同型半胱氨酸水平分析[J]. 预防医学,2020,32(1):80-82.
[4] 孔娟. 高同型半胱氨酸血症诊疗专家共识[J].肿瘤代谢与营养电子杂志,2020,7(3):283-288.
[5] MAJUMDER A,SINGH M,BEHERA J,et al.Hydrogen sulfide alleviates hyperhomocysteinemia-mediated skeletal muscle atrophy via mitigation of oxidative and endoplasmic reticulum stress injury[J]. Am J Physiol Cell Physiol,2018,315(5):609-622.
[6] LEE W J,PENG L N,LOH C H,et al.Sex-different associations between serum homocysteine,high-sensitivity C-reactive protein and sarcopenia:results from I-Lan Longitudinal Aging Study[J/OL]. Exp Gerontol,2020,132 [2024-01-22]. https://doi.org/10.1016/j.exger.2020.110832.
[7] 汪亚男,宋红玲,顾艳荭,等.老年2型糖尿病患者合并肌少症影响因素分析[J]. 预防医学,2019,31(6):582-585.
[8] 张媛,韩正风,马艳. 老年人群肌少症危险因素的病例对照研究[J]. 预防医学,2023,35(6):461-464.
[9] 陆冰,刘晔,陈吉海,等.住院老年患者血浆同型半胱氨酸水平与肌少症的相关性研究[J].中华全科医学,2021,19(11):1819-1822.
[10] CHEN L K,WOO J,ASSANTACHAI P,et al.Asian Working Group for Sarcopenia:2019 consensus update on sarcopenia diagnosis and treatment[J]. J Am Med Dir Assoc,2020,21(3):300-307.
[11] 中国老年医学学会高血压分会,北京高血压防治协会,国家老年疾病临床医学研究中心(中国人民解放军总医院,首都医科大学宣武医院),等.中国老年高血压管理指南2023[J].中华高血压杂志,2023,31(6):508-538.
[12] TER BORG S,DE GROOT L C,MIJNARENDS D M,et al. Differences in nutrient intake and biochemical nutrient status between sarcopenic and nonsarcopenic older adults-results from the Maastricht Sarcopenia Study[J]. J Am Med Dir Assoc,2016,17(5):393-401.
[13] PAN L Y,XIE W Q,FU X,et al.Inflammation and sarcopenia:a focus on circulating inflammatory cytokines[J/OL]. Exp Gerontol ,2021,154 [2024-01-22]. https://doi.org/10.1016/j.exger.2021.111544.
[14] CHHETRI J K,DE SOUTO BARRETO P,FOUGÈRE B,et al. Chronic inflammation and sarcopenia:a regenerative cell therapy perspective[J]. Exp Gerontol,2018,103:115-123.
[15] TAWFIK A,ELSHERBINY N M,ZAIDI Y,et al. Homocysteine and age-related central nervous system diseases:role of inflammation[J/OL]. Int J Mol Sci,2021,22(12)[2024-01-22]. https://doi.org/10.3390/ijms22126259.
[16] FANG P,LI X Y,SHAN H M,et al.Ly6C+ inflammatory monocyte differentiation partially mediates hyperhomocysteinemia-induced vascular dysfunction in type 2 diabetic db/db mice[J]. Arterioscler Thromb Vasc Biol,2019,39(10):2097-2119.
[17] VEERANKI S,LOMINDZE D,TYAGI S C.Hyperhomocysteinemia inhibits satellite cell regenerative capacity through p38 alpha/beta MAPK signaling[J]. Am J Physiol Heart Circ Physiol,2015,309(2):325-334.
[18] SINGH M,GEORGE A K,EYOB W,et al.High-methionine diet in skeletal muscle remodeling:epigenetic mechanism of homocysteine-mediated growth retardation[J]. Can J Physiol Pharmacol,2021,99(1):56-63. |
|
|
|
